The US Food and Drug Administration granted accelerated approval Friday for the Alzheimers disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the progression of co… [read more]
Alzheimer’s drug lecanemab receives accelerated approval amid safety concerns – CNN
You Might Also Like
Spinning off Instagram the decline of ‘friending’ and other takeaways from Mark Zuckerberg at the FTC monopoly trial – CNN
/cdn.vox-cdn.com/uploads/chorus_asset/file/21947011/fVqGMEj8Yvvajhj6SqHF9HKKIraBP_VI.jpg)
Google scraps $15 billion deal with lead developer of Silicon Valley campus projects – The Verge
